glp 1 bone loss Study reveals exercise and GLP-1 RA combination preserves health during weight Tirzepatide, a dual GLP-1 and

"DIABASI trial." J Endocr Soc 2018

Cell 38 , 733745 (2010)

While nausea, vomiting, and diarrhea are the most commonly reported gastrointestinal adverse effects with GLP-1-based therapies (occurring in 15-40% of patients depending on the agent and dose), FDA prescribing information for several of these medications does list dyspepsia (indigestion) and, in some cases, gastroesophageal reflux disease (GERD) as reported adverse reactions

Most symptoms improve between weeks three and six as appetite and digestion stabilize

Since we know that eating less food often means getting fewer nutrients, a high-quality multivitamin acts as an insurance policy: It can help fill in the gaps for nutrients of concern for people taking GLP-1s, like iron and vitamins D and B12

Cell Stress and Chaperones 30, 100085